Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
5,554,103
-
Share change
-
+175,164
-
Total reported value
-
$146,403,374
-
Price per share
-
$26.36
-
Number of holders
-
43
-
Value change
-
+$4,898,855
-
Number of buys
-
24
-
Number of sells
-
15
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2016
As of 30 Sep 2016,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,554,103 shares.
The largest 10 holders included
Novo A/S, FMR LLC, EMERALD ADVISERS INC/PA, EMERALD MUTUAL FUND ADVISERS TRUST, BlackRock Fund Advisors, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, JPMORGAN CHASE & CO, VANGUARD GROUP INC, STATE STREET CORP, and BlackRock Institutional Trust Company, N.A..
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.